CClinicalTrials.gg
Enrolling by invitationNCT07710508Updated Jul 23, 2026

Difference in Incontinence Prevalence Between High Impact Athletes, Low Impact Athletes and Sedentary Subjects

An observational study in Urinary Incontinence (UI) and Urinary Incontinence , Stress, sponsored by University of Valencia. Enrolling by invitation at 1 site in Spain. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-23.

Sponsored by University of Valencia · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
270
Ages
18 Years to 35 Years
Sex
All
01

Study summary

This observational cross-sectional study aims to investigate the association between participation in high-impact sports, physical activity level, and urinary incontinence in young adults. The study will compare six groups based on sex and physical activity level: male and female high-impact sports participants, physically active males and females who do not participate in high-impact sports, and sedentary males and females.

Participants aged 18-35 years will undergo a single assessment including sociodemographic and medical information, physical activity assessment, urinary incontinence questionnaires, sport-related characteristics, psychosocial questions regarding the influence of social taboos on questionnaire responses, lower-limb muscle strength testing using a load cell, and vertical jump performance assessment.

The study aims to describe the prevalence, severity, type, and impact of urinary incontinence across different activity levels and sexes, and to explore potential associations with lower-limb strength, jump performance, and sport-related characteristics.

Read the detailed description

Urinary incontinence is a common condition that may affect both women and men and has been associated with physical activity and participation in high-impact sports. Although regular exercise provides substantial health benefits, repetitive increases in intra-abdominal pressure during high-impact activities may contribute to pelvic floor dysfunction in susceptible individuals. Most previous studies have focused on female athletes from specific sports, while evidence including both sexes and different physical activity levels remains limited.

This observational cross-sectional study will compare urinary incontinence characteristics among six population groups defined according to sex and physical activity level: male and female participants in high-impact sports, physically active males and females who do not participate in high-impact sports, and sedentary males and females.

Participants will attend a single face-to-face assessment session after providing written informed consent. During the visit, sociodemographic and clinical information, physical activity characteristics, sport-related variables, urinary incontinence questionnaires, and psychosocial questions related to social taboos and response honesty will be collected. Lower-limb muscle strength will be assessed using a load cell system, and jump performance will be evaluated using the My Jump 2 application.

The primary objective is to compare the prevalence, severity, type, and impact of urinary incontinence across the different study groups. Secondary analyses will explore the relationship between urinary incontinence and physical activity level, lower-limb muscle strength, jump performance, sport-related characteristics, and selected demographic and clinical variables.

Participants will be recruited through social media, institutional dissemination, and sports clubs using voluntary convenience and snowball sampling. All assessments will be performed by trained researchers following standardized procedures.

02

Conditions studied

  • Urinary Incontinence (UI)
  • Urinary Incontinence , Stress

Keywords

  • urinary incontinence
  • physical activity
  • high-impact sports
03

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

The study population will consist of community-dwelling adults aged 18-35 years recruited from the general population and sports clubs. Participants will include males and females who regularly participate in high-impact sports, physically active individuals who do not participate in high-impact sports, and sedentary individuals. Recruitment will be conducted through social media, institutional advertisements, sports clubs, and snowball sampling. All participants will voluntarily contact the research team and will undergo a single face-to-face assessment after providing written informed consent.

Inclusion criteria

  • Adults aged 18 to 35 years.
  • Male or female participants.
  • Able to understand and provide written informed consent.
  • Belong to one of the following groups:

Regular participation in high-impact sports (≥2 training sessions per week for at least the previous 2 years).

Physically active individuals meeting the World Health Organization recommendations (≥150 minutes/week of moderate-intensity activity, ≥75 minutes/week of vigorous-intensity activity, or an equivalent combination), without regular participation in high-impact sports.

Sedentary individuals who do not meet the World Health Organization physical activity recommendations.

Exclusion criteria

Exclusion Criteria:

  • Pregnancy or childbirth within the previous 12 months.
  • Current or recent urinary tract infection.
  • History of urogynecological disease or pelvic/urogynecological surgery.
  • Body mass index (BMI) >35 kg/m².
  • Inability to understand or complete the study procedures or questionnaires in Spanish or English.
04

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
270 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Male High-Impact Sports Participants

    Males aged 18-35 years who regularly participate in high-impact sports (at least twice per week for the previous two years).

    Diagnostic Test: No Intervention: Observational Cohort

  • Female High-Impact Sports Participants

    Females aged 18-35 years who regularly participate in high-impact sports (at least twice per week for the previous two years).

    Diagnostic Test: No Intervention: Observational Cohort

  • Physically Active Males

    Males aged 18-35 years who meet the World Health Organization physical activity recommendations but do not participate in high-impact sports.

    Diagnostic Test: No Intervention: Observational Cohort

  • Physically Active Females

    Females aged 18-35 years who meet the World Health Organization physical activity recommendations but do not participate in high-impact sports.

    Diagnostic Test: No Intervention: Observational Cohort

  • Sedentary Males

    Males aged 18-35 years who do not meet the World Health Organization physical activity recommendations.

    Diagnostic Test: No Intervention: Observational Cohort

  • Sedentary Females

    Females aged 18-35 years who do not meet the World Health Organization physical activity recommendations.

    Diagnostic Test: No Intervention: Observational Cohort

Interventions

  • Diagnostic testNo Intervention: Observational Cohort

    No intervention

05

What researchers measure

Primary outcomes

  1. Urinary incontinence severity

    Urinary incontinence severity assessed using the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF). Higher scores indicate greater symptom severity and impact on quality of life. The total score ranges from 0 to 21, with higher scores indicating more severe urinary incontinence symptoms and greater impact on quality of life.

    Time frame: Baseline (single study visit)

Secondary outcomes

  1. Urinary incontinence-related quality of life

    Quality of life associated with urinary incontinence assessed using the Incontinence Quality of Life Questionnaire (I-QOL). The total score ranges from 0 to 100, with higher scores indicating better urinary incontinence-related quality of life.

    Time frame: Baseline (single study visit)

  2. Lower-limb muscle strength

    Maximum voluntary force and mean voluntary force of hip adduction, abduction, flexion, extension, internal rotation, and external rotation measured using a load cell and ChronoJump software.

    Time frame: Baseline (single study visit)

  3. Vertical jump performance

    Vertical jump performance assessed using the My Jump 2 application.

    Time frame: Baseline (single study visit)

  4. Physical activity level

    Physical activity level assessed using the International Physical Activity Questionnaire (IPAQ). Physical activity is expressed as metabolic equivalent (MET)-minutes per week and classified into low, moderate, or high physical activity levels, according to the IPAQ scoring protocol. Higher MET-minutes per week indicate greater levels of physical activity.

    Time frame: Baseline (single study visit)

06

Study locations

1 site
  • Gascó Oliag, 5
    Valencia, Valencia 46010, Spain
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07710508
Lead sponsor
University of Valencia
Responsible party
Noemi Moreno-Segura (Assistant professor, University of Valencia) — Principal investigator
First posted
Jul 17, 2026
Start date
Sep 24, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Jul 23, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion